Pricing Log in Create free account
Saturday 17 October 2026 Export MRNA’s income statement to Excel — free account

Moderna, Inc.

MRNA Healthcare Biotechnology

Moderna, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.9 billion, down 39.9% from fiscal 2024. In the quarter to June 2026, revenue grew 2.11%, EPS grew 7.51%, free cash flow grew 38.9% and total debt rose 1,765.6%, each against the same quarter a year earlier. Member of the S&P 500 and Nasdaq 100.

218.01 18.49 −7.82%
Market cap
$94.4B
P/E
0.0×
Fwd P/E
−5.5×
Dividend yield
—
F-score
3/9
Altman Z
2.46
Beneish M
−3.52
Dividend safety
n/a
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

Moderna, Inc. (MRNA) Current ratio

Alert me on Current ratio

Moderna, Inc.'s current ratio at the end of the quarter to 30 June 2026 was 2.3×, down 1.0× from fiscal 2025 (3.3×). Over the past ten years it has ranged from 1.4× (fiscal 2020) to 7.9× (fiscal 2019); the current reading is higher than 40% of that period. That is below the Biotechnology industry median of 4.7× and below the Healthcare sector median of 3.0×.

Current ratio, annual

Embed this chart

Annual newest first

Period Current ratio Change
FY2025 3.3× (10.30%)
FY2024 3.7× 7.21%
FY2023 3.4× 25.52%
FY2022 2.7× 54.96%
FY2021 1.8× 22.69%
FY2020 1.4× (81.81%)
FY2019 7.9× 12.43%
FY2018 7.0× 71.49%
FY2017 4.1× (38.74%)
FY2016 6.7× —

Quarterly newest first

Period Current ratio Change
Jun 2026 2.3× (4.75%)
Mar 2026 2.4× (26.85%)
Dec 2025 3.3× (16.09%)
Sep 2025 3.9× (0.02%)
29 more quarters

Against its own ten years

Low 1.4× High 7.9×
Ten-year median 3.5×
Current reading's percentile 40

Current ratio against peers

Company Current ratio
ROIV Roivant Sciences Ltd. compare 16.7×
RVMD Revolution Medicines, Inc. compare 11.4×
ARGX argenex SE compare 5.1×
ONC BeOne Medicines Ltd. - Sponsored ADR compare 3.4×
REGN Regeneron Pharmaceuticals, Inc. compare 3.3×
VRTX Vertex Pharmaceuticals Incorporated compare 3.2×
ALNY Alnylam Pharmaceuticals, Inc. compare 3.1×
RPRX Royalty Pharma PLC compare 2.8×
MRNA Moderna, Inc. 2.3×
Biotechnology industry median 4.7×
Healthcare sector median 3.0×
Market median 1.6×

What Current ratio is

Current Ratio shows whether a company’s short-term assets are enough to cover the bills and debts it must pay within the next year.

Current Assets (Total) ÷ Current Liabilities (Total)

The full definition of Current ratio →

More on MRNA